Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001657705-16-000003
Filing Date
2016-07-08
Accepted
2016-07-08 14:35:45
Documents
1
Period of Report
2016-07-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3198
  Complete submission text file 0001657705-16-000003.txt   4853
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 80 TIPTOE LANE BURLINGAME CA 94010
Business Address
Nejadnik Bijan (Reporting) CIK: 0001657705 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 161758883